Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

bubs australia

  • Home
  •  
  • bubs australia



  • Most Read
  • Latest Comments
  • Bubs lodges letter of intent with FDA to become a permanent seller in the USA
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Bubs lodges letter of intent with FDA to become a permanent seller in the USA
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Bubs lodges letter of intent with FDA to become a permanent seller in the USA
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Bubs lodges letter of intent with FDA to become a permanent seller in the USA
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Bubs lodges letter of intent with FDA to become a permanent seller in the USA
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Bubs enrols 400th infant in its US clinical trials to get baby formula approval
    Bubs enrols 400th infant in its US clinical trials to get baby formula approval
    • News

  • Bubs Australia rebounds in China after CEO fiasco, sees USA growth
    Bubs Australia rebounds in China after CEO fiasco, sees USA growth
    • News

  • Bubs goes full steam ahead with US FDA trials in rising market for infant formula
    Bubs goes full steam ahead with US FDA trials in rising market for infant formula
    • News

  • Bubs presents its rebound plan after bitter breakup with former CEO and Chairman
    Bubs presents its rebound plan after bitter breakup with former CEO and Chairman
    • News

  • Un-Happy Valley Nutrition: infant formula company collapses as director and CFO walk out
    Un-Happy Valley Nutrition: infant formula company collapses as director and CFO walk out
    • News

  • Bubs lodges letter of intent with FDA to become a permanent seller in the USA
    • News

    Bubs lodges letter of intent with FDA to become a permanent seller in the USA

    After a successful entry into the USA during their recent dairy crisis, infant nutrition and dairy specialist Bubs Australia (ASX: BUB) has lodged a letter of intent to continue selling six Bubs Infant Formula products in the country till October 2025 and beyond. The Australian Company is one of only eight infant formula manufacturers globally

    Read More
    Public
  • Bubs to the rescue as special operation gets underway
    • News

    Bubs to the rescue as special operation gets underway

    Shareholders of Bubs Australia (ASX: BUB) reveled in every small cap investors’ dream over the weekend – a direct shoutout from the President of the United States. And this morning the President issued a follow-up that will renew shareholders’ excitement – it might not quite get the attention of an incendiary ex President Trump tweet,

    Read More
    Public
  • Bubs executes $12 million turnaround with diversification strategy
    • News

    Bubs executes $12 million turnaround with diversification strategy

    Remember when busloads of Chinese tourists would rock up at your local supermarket and clear out the shelves of baby formulae which they then sent back to China and sold at a premium? It turns out those guys were pretty important to Australia’s milk powder industry which tanked when international border restrictions stopped them from

    Read More
    Public
  • Bubs clears regulatory pathway with breakthrough China collaboration
    • News

    Bubs clears regulatory pathway with breakthrough China collaboration

    With trade tensions between Australia and China bubbling, dairy products company Bubs Australia (ASX: BUB) has mitigated their potential risk exposure through an agreement with China-based Beingmate which will package and mass distribute their 100% Australian goats milk formula. In particular, the collaboration will seek a State Administration for Market Regulation (SAMR) brand slot which

    Read More
    Public
  • Latest IPO taps wholesale appetite for plant-based proteins
    • Opinion

    Latest IPO taps wholesale appetite for plant-based proteins

    The latest company to brave the sparse list of new ASX listings can’t be accused of being off-trend when it comes to tapping the dietary habits of younger inner-urban consumers that are more about quinoa and chia and less about KFC. In the throes of a $6 million raising, Forbidden Foods (FFF) claims to have

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.